Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Achiral inhibitors of carnitine palmitoyltransferase I

Sep. 13, 1996

Chugai's metabolic drug R&D pipeline

Sep. 13, 1996

Rapamycin in anemia

Sep. 13, 1996

Warner-Lambert profiles ACAT inhibitors with hypocholesterolemic and antiatherosclerotic activity

Sep. 13, 1996

Vitamin D3 derivatives for osteoporosis

Sep. 13, 1996

New estrogen agonists and antagonists

Sep. 13, 1996

Novel treatment for bone loss

Sep. 13, 1996

Meiji Seika discloses natural progesterone antagonists

Sep. 6, 1996

U.S. approval for Serono infertility product

Sep. 6, 1996

Moxisylyte to treat erectile dysfunction

Sep. 6, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.